PPBT
Purple Biotech
PPBT
PPBT
4 hedge funds and large institutions have $56K invested in Purple Biotech in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TSS
Two Sigma Securities
New York
|
$23K |
| 2 |
UBS Group
Zurich,
Switzerland
|
$10K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TSS
1
Two Sigma Securities
New York
| $23K | +$23K | +53 | New |
|
2
Wells Fargo
San Francisco,
California
| $22K | -$8.8K | -20 | -29% |
|
|
3
UBS Group
Zurich,
Switzerland
| $10K | +$435 | +1 | +5% |
|
|
AG
4
Advisor Group
Phoenix,
Arizona
| $1K | -$2K | -4 | -67% |
|
|
VF
5
Virtu Financial
New York
| – | -$67K | -148 | Closed |
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$38K | -83 | Closed |
|
|
OAM
7
Oxford Asset Management
Oxford,
United Kingdom
| – | -$29K | -62 | Closed |
|